BioNexus Gene Correlations

BGLC Stock  USD 4.94  0.16  3.14%   
The current 90-days correlation between BioNexus Gene Lab and BioMark Diagnostics is -0.02 (i.e., Good diversification). The correlation of BioNexus Gene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

BioNexus Gene Correlation With Market

Good diversification

The correlation between BioNexus Gene Lab and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BioNexus Gene Lab and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNexus Gene Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with BioNexus Stock

  0.66DD Dupont De Nemours Earnings Call Next WeekPairCorr
  0.64FSI Flexible SolutionsPairCorr

Moving against BioNexus Stock

  0.4FEAM 5E Advanced MaterialsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BMKDFBIOF
SNESBIOF
SNESBMKDF
EDTXFBIOF
EDTXFBMKDF
MBXBFKBLB
  
High negative correlations   
MBXBFBMKDF
SNESMBXBF
MBXBFBIOF
KBLBBIOF
KBLBBMKDF
SNESKBLB

Risk-Adjusted Indicators

There is a big difference between BioNexus Stock performing well and BioNexus Gene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BioNexus Gene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

BioNexus Gene Corporate Management

Sook YeohCEO DirectorProfile
Kwan ChanMarketing ManagerProfile
Too ThamManaging DirectorProfile
Wei LeongCFO OfficerProfile